SciELO - Scientific Electronic Library Online

 
vol.35 número6Satisfacción con la residencia de Cirugía Pediátrica en México: Resultados de una encuesta de opiniónEstabilidad fisicoquímica y microbiológica de captopril en formulación extemporánea índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Acta pediátrica de México

versión On-line ISSN 2395-8235versión impresa ISSN 0186-2391

Resumen

TRIGO-MADRID, Max et al. Expanded newborn screening in the Health Services of the Mexican Navy. Acta pediatr. Méx [online]. 2014, vol.35, n.6, pp.448-458. ISSN 2395-8235.

In Mexico the birth prevalence of the metabolic diseases detected by expanded newborn screening is poorly known and there is little information about its performance indicators. Objective. Describe the birth prevalence of the metabolic defects detected by the expanded newborn screening program implemented in the Mexican Navy (Secretaría de Marina Armada de México, SEMAR), and to make known some of its performance indicators. Materials and Methods. A blood sample of 5 205 newborns from 18 Mexican states were taken. The age at blood sampling, the proportion of samples taken between the 3rd and the 5th days of life, and the time of results delivery were analyzed. The number and type of detected metabolic diseases, as well as the maternal age and body mass index, the type of birth, the gestational age and weight of the newborns were analized. Results. The age at blood sampling was 4.7 days and 81.15 percent of the samples were obtained in optimal time. Two cases of congenital hypothyroidism (3.8/10 000 newborns), one of adrenal congenital hyperplasia (1.9/10 000 newborns) and five cases of deficiency of glucose-6-phosphate dehydrogenase (9.6/10 000 newborns) were detected. The 85.6% of mothers had pregnancies at an optimal reproductive age (20-35 years), but overweight and obesity occurred in 44.7% of them. Conclusions. In this analyzed population, the birth prevalence of metabolic defects was 15.37/10 000 newborns. The expanded newborn screening program allowed its identification and timely treatment, with the aim of preventing disability and death.

Palabras llave : neonatal screening; birth defects; metabolic diseases; inborn errors of metabolism; prevention and control.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons